Thermal acupuncture for cervical artery cervical spinal disease liver and kidney deficiency

Objective To investigate the efficacy of “cervical lumbar homogenesis” on hepatic and renal deficiency of vertebral arterial cervical disease (CSA) and the effect on serum endothelin (ET), prostagcyclin (PGI2), endothelial hyperpolarization factor (EDHF). Methods 112 patients with CSA were randomly divided into control groups (56 cases example). Both groups of patients were given maxillary occipital traction therapy 1 time/d. Fluurrizine hydrochloride, 5 mg/d. Thermal acupuncture treatment in the treatment group “cervical lumbar homozyme”, 1 it/d, weekly treatment 6 d. Continuous treatment in both groups 4 w. Comparison of the clinical evaluation scale (CASCS), cervical vertigo symptoms and function, hepatic insufficiency symptoms score and arial doppler blood flow Analysis of clinical efficacy after 4 w of treatment in two groups Detection of serum ET, PGI2, EDHF levels in two groups. Comparing the incidence of adverse reactions in the two groups. After treatment, CASCS and cervical vertigo symptoms and functional scores were significantly higher than the control group (P<0.01), the vertebral artery blood flow rate and caliber was significantly higher than the control group (P<0.01), symptoms (P<0.01) Vertigo, headache, tinnitus, insomnia, numbness of limbs) score Significantly lower than the control group (P<0.01); after treatment 4 w, the treatment group had significantly greater efficiency than the control group (P<0.05). After treatment, serum ET levels were significantly lower than the control group, PGI2 and EDHF levels were significantly higher than the control group (P0.05<0.01). 两 组 不 良 反 应 发 生 率 比 较 差 异 无 统 计 学 意 义 (P>). Acupuncture treatment of CSA hepatic and renal deficiencies can significantly improve the patient's clinical symptoms, vertebral artery blood flow indicators and symptomatic symptoms, improve clinical efficacy, and safety, and regulate ET, PGI2, EDHF levels in the patient's body may be one of the pathways of efficacy.